2BB score and signals
Anbio Biotechnology’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 13 | Very Low |
| Momentum | 52 | Stable |
| Financial strength | 97 | Very Strong |
| Quality | 60 | Strong |
| Risk | 46 | Moderate |
2BBBullish & Bearish
Anbio Biotechnology (NNNN) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 24 out of 100.
Anbio Biotechnology’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 13 | Very Low |
| Momentum | 52 | Stable |
| Financial strength | 97 | Very Strong |
| Quality | 60 | Strong |
| Risk | 46 | Moderate |
| Founded | 2021 |
| Employees | 27 |
| P/E ratio | 24.35 |
| 52-week range | $3.52 – $44.73 |